Areia A, Galvão A, Pais M S J, Freitas L, Moura P
Department of Obstetrics, Coimbra University Hospital, 3000 Coimbra, Portugal.
Arch Gynecol Obstet. 2009 Mar;279(3):273-7. doi: 10.1007/s00404-008-0711-7. Epub 2008 Jun 21.
To evaluate risk factors affecting pregnancy, perinatal outcomes and graft condition in women who underwent renal transplantation.
Retrospective study of 34 pregnancies in 28 renal recipients followed in a single tertiary center from January 1989 to January 2007.
Pregnancy outcome, kidney allograft function, maternal complications and perinatal outcomes were evaluated in these patients.
Mean maternal age at time of pregnancy was 27+/-5.1 years (18-37) and the interval between transplant and pregnancy varied between 1 and 134 months (mean 51.3+/-34.2). Most pregnant women (25/28) were submitted to triple immunosuppression during the entire pregnancy. The fetal outcome included 27 live births (79.4%), 2 stillbirths (5.9%), 3 spontaneous abortions (8.8%) and 2 therapeutic abortions (5.9%). The most frequent maternal complications were hypertension in 18 pregnancies, 2 of which ended in pre-eclampsia; urinary tract infections in 10 pregnancies; gestational diabetes mellitus in 3, anemia in 3 and 2 acute graft rejections. The major fetal complications observed consisted of four (13. 8%) intrauterine growth restrictions and two (6.9%) stillbirths. Vaginal delivery occurred in 10 women (34.5%); in the other 19 (65.5%), a cesarean section was performed. Of the 27 successful pregnancies, 11 (40.7%) resulted in term deliveries and 16 (59.3%) in preterm deliveries (range 31-39 weeks). The mean birth weight of the offspring was 2,465 g (range 1,300-3,530). There were no major perinatal complications, but two allograft rejections occurred after pregnancy.
This series results are in agreement with those in other studies. Even though pregnancy does not seem to adversely affect short-term renal allograft function, risks of obstetric and perinatal complications seem to be increased. Further studies of long term graft function and pediatric follow-up are needed.
评估影响接受肾移植女性的妊娠、围产期结局及移植肾状况的危险因素。
对1989年1月至2007年1月在单一三级中心随访的28例肾移植受者中的34次妊娠进行回顾性研究。
评估这些患者的妊娠结局、肾移植功能、母体并发症及围产期结局。
妊娠时的平均产妇年龄为27±5.1岁(18 - 37岁),移植与妊娠之间的间隔时间在1至134个月之间(平均51.3±34.2个月)。大多数孕妇(25/28)在整个孕期接受三联免疫抑制治疗。胎儿结局包括27例活产(79.4%)、2例死产(5.9%)、3例自然流产(8.8%)和2例治疗性流产(5.9%)。最常见的母体并发症为18例妊娠合并高血压,其中2例发展为子痫前期;10例妊娠合并尿路感染;3例妊娠合并妊娠期糖尿病,3例妊娠合并贫血,2例发生急性移植肾排斥反应。观察到的主要胎儿并发症包括4例(13.8%)胎儿生长受限和2例(6.9%)死产。10名女性(34.5%)经阴道分娩;其他19名女性(65.5%)行剖宫产。在27例成功妊娠中,11例(40.7%)为足月分娩,16例(59.3%)为早产(孕周31 - 39周)。后代的平均出生体重为2465克(范围1300 - 3530克)。未发生重大围产期并发症,但妊娠后发生了2例移植肾排斥反应。
本系列研究结果与其他研究一致。尽管妊娠似乎不会对肾移植短期功能产生不利影响,但产科和围产期并发症的风险似乎有所增加。需要进一步研究长期移植肾功能及儿科随访情况。